LGND
Ligand Pharmaceuticals Incorporated
NASDAQ: LGND · HEALTHCARE · BIOTECHNOLOGY
$224.86
-3.21% today
Updated 2026-04-29
Market cap
$2.73B
P/E ratio
36.74
P/S ratio
10.17x
EPS (TTM)
$6.12
Dividend yield
—
52W range
$99 – $247
Volume
0.2M
Ligand Pharmaceuticals Incorporated (LGND) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-138.52M | $-97.73M | $-20.63M | $-33.80M | $-27.07M | $-1.17M | $161000.00 | $20.69M | $20.57M | $41.73M | $63.00M | $93.57M | $194.06M | $-29.34M | $54.59M | $78.80M | $137.85M | $49.58M | $97.05M | $49.36M |
| Capital expenditures | $1.78M | $440000.00 | $495000.00 | $522000.00 | $70000.00 | $78000.00 | $8.64M | $4.94M | $4.50M | $10.86M | $28.32M | $7.15M | $11.89M | $2.55M | $4.46M | $8.76M | $17.92M | $53.85M | $19.64M | $452000.00 |
| Depreciation | $16.22M | $2.62M | $1.05M | $3.13M | $2.21M | $2.79M | $2.73M | $2.66M | $2.66M | $2.63M | $11.29M | $11.71M | $14.72M | $43.73M | $27.97M | $50.95M | $51.37M | $36.52M | $35.24M | — |
| Stock-based comp | $5.34M | $7.58M | $-537000.00 | $3.37M | $2.33M | $3.35M | $4.07M | $5.67M | $11.27M | $12.46M | $18.89M | $24.91M | $20.85M | $24.52M | $30.73M | $38.78M | $60.28M | $25.74M | $41.09M | $46.85M |
| Free cash flow | $-140.30M | $-98.17M | $-21.12M | $-34.32M | $-27.14M | $-1.25M | $-8.48M | $15.75M | $16.07M | $30.86M | $34.68M | $86.41M | $182.17M | $-31.89M | $50.13M | $70.04M | $119.93M | $-4.27M | $77.41M | $48.91M |
| Investing cash flow | $196.87M | $343.84M | $-24.42M | $24.77M | $14.54M | $-25.13M | $1.26M | $-4.97M | $-2.03M | $-112.86M | $-143.19M | $-84.18M | $-423.27M | $466.92M | $231.65M | $30.52M | $163.62M | $-11.68M | $-143.66M | — |
| Financing cash flow | $33.30M | $-327.70M | $-3.01M | $-3.69M | $-159000.00 | $30.00M | $3.92M | $-16.46M | $130.03M | $8.36M | $1.51M | $-7.52M | $328.58M | $-485.17M | $-310.55M | $-137.76M | $-275.99M | $-59.95M | $97.14M | — |
| Dividends paid | — | $252.56M | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $3.00M | $3.02M | $15.32M | $5.00M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $3.69M | $5.34M | — | $-742000.00 | $-62.77M | $-78.68M | $1.87M | $99.38M | $-47.59M | $-24.31M | $-28.44M | — | — | — | — |